Clinical Trial Update: A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring [Phase 3]

View source ↗

Summary

Phase 3 study evaluating tolterodine extended-release versus propiverine for overactive bladder in Korean patients, assessed by ambulatory urodynamic monitoring…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Detrol LA (tolterodine tartrate)
• Propiverine (propiverine)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED